Huayi Capital
Overview
Huayi Capital is a venture capital firm established in 2015 that focuses on early and growth-stage investments in the healthcare sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jiangsu Only Three Biotechnology Co., Ltd. | Apr 2025 | Early Funding | Co-investor |
| Xenta Biomedical Science (Guangzhou) Medical Technology Co., Ltd. | Oct 2025 | Series A | Lead |
| Lewei Pharmaceutical | Aug 2019 | Series B | Lead |
| Fushoukang (Shanghai) Medical Elderly Care Service Co., Ltd. | Sep 2018 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Huayi Capital based?
Huayi Capital is headquartered in Shanghai, China.
When was Huayi Capital founded?
Huayi Capital was founded in 2015.
How many portfolio companies does Huayi Capital have?
Huayi Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Huayi Capital's portfolio?
Portfolio companies visible on Caplight include Jiangsu Only Three Biotechnology Co., Ltd., Xenta Biomedical Science (Guangzhou) Medical Technology Co., Ltd., Lewei Pharmaceutical, Fushoukang (Shanghai) Medical Elderly Care Service Co., Ltd..
What was Huayi Capital's most recent investment shown here?
Huayi Capital's most recent investment in this portfolio sample was in Xenta Biomedical Science (Guangzhou) Medical Technology Co., Ltd. in 2025.
What sectors does Huayi Capital focus on?
Huayi Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Consumer & Commerce, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Huayi Capital focus on?
Stage focus information for Huayi Capital is not publicly available.